What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Surgery
His primary scientific interests are in Internal medicine, Cardiology, Angioplasty, Surgery and Restenosis.
His study in Coronary artery disease, Percutaneous coronary intervention, Conventional PCI, Randomized controlled trial and TIMI is done as part of Internal medicine.
His Cardiology study integrates concerns from other disciplines, such as Stent and Coronary stent.
His work in Angioplasty tackles topics such as Stenosis which are related to areas like Randomization and Clinical trial.
His biological study spans a wide range of topics, including Creatinine metabolism, Urology, Acute coronary syndrome and Intensive care medicine.
His Restenosis study combines topics from a wide range of disciplines, such as Placebo, Percutaneous, Complication and Balloon.
His most cited work include:
- Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). (1544 citations)
- Strategies for Multivessel Revascularization in Patients with Diabetes (1215 citations)
- Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS). (928 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Cardiology, Myocardial infarction, Angioplasty and Surgery.
His work on Coronary artery disease, Percutaneous coronary intervention and Perindopril as part of his general Internal medicine study is frequently connected to In patient, thereby bridging the divide between different branches of science.
Many of his studies involve connections with topics such as Angiography and Cardiology.
The Myocardial infarction study combines topics in areas such as Randomized controlled trial and Ejection fraction.
In his study, which falls under the umbrella issue of Angioplasty, Balloon, Complication and Percutaneous transluminal coronary angioplasty is strongly linked to Restenosis.
His research integrates issues of Diabetes mellitus, Aspirin and Clinical trial in his study of Surgery.
He most often published in these fields:
- Internal medicine (72.82%)
- Cardiology (59.93%)
- Myocardial infarction (27.53%)
What were the highlights of his more recent work (between 2009-2017)?
- Internal medicine (72.82%)
- Cardiology (59.93%)
- Myocardial infarction (27.53%)
In recent papers he was focusing on the following fields of study:
Michel E. Bertrand focuses on Internal medicine, Cardiology, Myocardial infarction, Perindopril and Coronary artery disease.
His Internal medicine research includes themes of Placebo and Surgery.
In the subject of general Cardiology, his work in Percutaneous coronary intervention, Revascularization, TIMI and Angioplasty is often linked to In patient, thereby combining diverse domains of study.
His Angioplasty research is multidisciplinary, incorporating elements of Lesion and Atherectomy.
His work is dedicated to discovering how Myocardial infarction, Stroke are connected with Proportional hazards model and other disciplines.
The study incorporates disciplines such as Statin, Framingham Risk Score, Atorvastatin and Heart failure in addition to Coronary artery disease.
Between 2009 and 2017, his most popular works were:
- Strategies for Multivessel Revascularization in Patients with Diabetes (1215 citations)
- Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158 998 patients (288 citations)
- Impact of Bleeding on Mortality After Percutaneous Coronary Intervention: Results From a Patient-Level Pooled Analysis of the REPLACE-2 (Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events), ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy), and HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trials (286 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Surgery
The scientist’s investigation covers issues in Internal medicine, Cardiology, Myocardial infarction, Coronary artery disease and Revascularization.
His Internal medicine research focuses on Endocrinology and how it relates to Hazard ratio.
His Myocardial infarction research incorporates themes from Stroke and Aldosterone.
His research on Coronary artery disease frequently connects to adjacent areas such as Angioplasty.
His study in Angioplasty is interdisciplinary in nature, drawing from both Brain natriuretic peptide, Spironolactone, Ejection fraction and Heart failure.
His Revascularization research includes elements of Ischemia and Percutaneous coronary intervention.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
